Skip to content

Rapid Micro Biosystems RPID Remainder of Fiscal Year 2024

Remainder of Fiscal Year 2024 at other companies

Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
Pacific Biosciences of California logo
Pacific Biosciences of CaliforniaPACB
iRadimed logo
iRadimedIRMD
Ginkgo Bioworks logo
Ginkgo BioworksDNA
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
Lifecore Biomedical, Inc. logo
Lifecore Biomedical, Inc.LFCR

Other financials

Income statement

See full
Revenue$8.0M+11.1%
Gross profit$371.0K-8.2%
Operating income-$13.9M-18.8%
Net income-$14.3M-26.7%
EPS (diluted)-$0.31-19.2%

Balance sheet

See full
Cash & equivalents$14.1M-26.8%
Total debt$23.8M+301%
Total equity$20.4M-68.9%
Total assets$62.4M-27.0%

Cash flow

See full
Operating cash flow-$15.1M-66.1%
CapEx$394.0K+23.5%
Free cash flow-$15.5M-64.7%

Valuation

See full
Market cap$86.19M-43.8%
Enterprise value$95.86M-31.7%
P/S2.5×-2.6×

Profitability

See full
Operating margin-144.2%-12.7pp
Net margin-145.8%-5.0pp
FCF margin-110.5%-14.9pp

Returns & leverage

See full
Return on equity-116.7%-620pp
Debt / equity1.2×+1.1×
Current ratio2.6×-2.0×

Where this comes from

Reported directly by Rapid Micro Biosystems in its filing.

Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear.

The official record: Rapid Micro Biosystems’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rapid Micro Biosystems's remainder of fiscal year 2024.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Rapid Micro Biosystems's remainder of fiscal year 2024?
Rapid Micro Biosystems (RPID) reported remainder of fiscal year 2024 of $1.05M in Q1 2026.
How has Rapid Micro Biosystems's remainder of fiscal year 2024 changed year-over-year?
Rapid Micro Biosystems's remainder of fiscal year 2024 increased by 2.4% year-over-year, from $1.03M to $1.05M.